Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.

ABSTRACT:

Background

The choice of drugs for patients with status epilepticus that is refractory to treatment with benzodiazepines has not been thoroughly studied.

Methods

In a randomized, blinded, adaptive trial, we compared the efficacy and safety of three intravenous anticonvulsive agents - levetiracetam, fosphenytoin, and valproate - in children and adults with convulsive status epilepticus that was unresponsive to treatment with benzodiazepines. The primary outcome was absence of clinically evident seizures and improvement in the level of consciousness by 60 minutes after the start of drug infusion, without additional anticonvulsant medication. The posterior probabilities that each drug was the most or least effective were calculated. Safety outcomes included life-threatening hyp

SUBMITTER: Kapur J 

PROVIDER: S-EPMC7098487 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature